groups » Dengue Therapeutics Discussion Area » Combating growing insecticide resistance

Insecticide resistance has reached a tipping point. “Mosquitoes have developed resistance to all the major classes of insecticides,” says Dr. Sarah Rees, Portfolio Manager at the Innovation Vector Control Consortium (IVCC). “This makes the development of new insecticides for vector control increasingly urgent.”
But getting new insecticides to market can take a great deal of time and money. And even when new products arrive, encouraging organizations to adopt them and people to use them can be challenging.

Established in 2005, the IVCC public-private product development partnership is helping to bring new classes of insecticides to market more rapidly. A not-for-profit company, IVCC works with multiple stakeholders to remove the barriers to innovation in the vector control.
As a registered charity, IVCC’s work depends on donations. Major donors include The Bill & Melinda Gates Foundation, UKAID, USAID and the Swiss Agency for Development and Cooperation. IVCC uses those funds to develop new insecticides, in agreement with funders.
“Our role is to ensure funders’ money is spent appropriately and not wasted on something that isn’t likely to work or isn’t going to be safe,” says Dr. Rees.

Read full article:


Aedes Aegypti dengue fever drug resistance Insecticide mosquito control mosquitoes pest control

Please Sign in (or Register) to view further.